A detailed history of State Of Wisconsin Investment Board transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 37,096 shares of NRIX stock, worth $808,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,096
Previous 35,138 5.57%
Holding current value
$808,321
Previous $733,000 13.51%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.93 - $25.69 $37,064 - $50,301
1,958 Added 5.57%
37,096 $832,000
Q2 2024

Aug 14, 2024

BUY
$12.02 - $21.3 $422,358 - $748,439
35,138 New
35,138 $733,000
Q4 2023

Feb 12, 2024

SELL
$4.25 - $10.71 $15,967 - $40,237
-3,757 Reduced 13.59%
23,891 $246,000
Q3 2023

Nov 14, 2023

SELL
$7.86 - $10.08 $2,743 - $3,517
-349 Reduced 1.25%
27,648 $217,000
Q2 2023

Aug 14, 2023

SELL
$8.7 - $13.28 $11,118 - $16,971
-1,278 Reduced 4.37%
27,997 $279,000
Q1 2023

May 15, 2023

SELL
$8.56 - $13.26 $27,623 - $42,790
-3,227 Reduced 9.93%
29,275 $259,000
Q4 2022

Feb 14, 2023

SELL
$9.86 - $14.59 $18,664 - $27,618
-1,893 Reduced 5.5%
32,502 $356,000
Q3 2022

Nov 14, 2022

BUY
$12.33 - $19.81 $118,392 - $190,215
9,602 Added 38.73%
34,395 $448,000
Q2 2022

Aug 15, 2022

SELL
$7.88 - $14.82 $123,771 - $232,777
-15,707 Reduced 38.78%
24,793 $314,000
Q2 2021

Aug 12, 2021

BUY
$24.21 - $35.89 $600,408 - $890,072
24,800 Added 157.96%
40,500 $1.07 Million
Q4 2020

Feb 03, 2021

BUY
$22.85 - $48.44 $358,745 - $760,508
15,700 New
15,700 $516,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.03B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.